
样式: 排序: IF: - GO 导出 标记为已读
-
Efficacy and safety of upadacitinib for 16-week extended induction and 52-week maintenance therapy in patients with moderately to severely active ulcerative colitis Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2023-11-27 Remo Panaccione, Silvio Danese, Wen Zhou, Justin Klaff, Dapo Ilo, Xuan Yao, Gweneth Levy, Peter D. R. Higgins, Edward V. Loftus, Su Chen, Yuri Sanchez Gonzalez, Carolyn Leonard, Xavier Hébuterne, James O. Lindsay, Qian Cao, Hiroshi Nakase, Jean-Frédéric Colombel, Séverine Vermeire
-
Longitudinal changes in renal function in patients with chronic hepatitis B on antiviral treatment Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2023-11-27 Hyeyeon Hong, Minjoo Cho, Chaeyeon Lim, Won-Mook Choi, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim, Han Chu Lee, Jonggi Choi
-
Editorial: Assessing advanced fibrosis in metabolic-associated steatotic liver disease—The MAFLD fibrosis score Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2023-11-20 Suzanne Sharpton
This article is linked to Cheung et al papers. To view these articles, visit https://doi.org/10.1111/apt.17722 and https://doi.org/10.1111/apt.17774
-
Meta-analysis: Impact of intragastric balloon therapy on NAFLD-related parameters in patients with obesity Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2023-11-20 Olufemi Aoko, Tobias Maharaj, Fiona Boland, Danny Cheriyan, John Ryan
-
Editorial: On-demand vonoprazan for NERD—when should it be ‘demanded’? Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2023-11-20 Peter J. Kahrilas
This article is linked to Fass et al papers. To view these articles, visit https://doi.org/10.1111/apt.17728 and https://doi.org/10.1111/apt.17766
-
Editorial: On-demand vonoprazan for NERD – when should it be ‘demanded’? Authors' reply Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2023-11-20 Ronnie Fass, David Armstrong
This article is linked to Fass et al papers. To view these articles, visit https://doi.org/10.1111/apt.17728 and https://doi.org/10.1111/apt.17737
-
Editorial: Unravelling the relationship between periodontal disease and inflammatory bowel disease Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2023-11-20 Jiho Sohn
This article is linked to Williams et al paper. To view this article, visit https://doi.org/10.1111/apt.17732
-
Editorial: Assessing advanced fibrosis in metabolic-associated steatotic liver disease—the MAFLD fibrosis score. Authors' reply Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2023-11-20 Johnny T. K. Cheung, Wah Kheong Chan, Ming-Hua Zheng, Vincent Wai-Sun Wong
This article is linked to Cheung et al papers. To view these articles, visit https://doi.org/10.1111/apt.17722 and https://doi.org/10.1111/apt.17744
-
Editorial: Liver hypercortisolism as a potential target for MASH treatment Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2023-11-20 Stephen A. Harrison, Julie Dubourg
This article is linked to Kim et al papers. To view these articles, visit https://doi.org/10.1111/apt.17726 and https://doi.org/10.1111/apt.17780
-
Editorial: Liver hypercortisolism as a potential target for MASH treatment—Authors' reply Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2023-11-20 Yun Kim, Inyoung Hwang, Sang W. Lee
This article is linked to Kim et al papers. To view these articles, visit https://doi.org/10.1111/apt.17726 and https://doi.org/10.1111/apt.17757
-
Letter: Tofacitinib, vedolizumab and ustekinumab in patients with ulcerative colitis Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2023-11-20 Hui-Chin Chang, Shuo-Yan Gau
This article is linked to Kochhar et al papers. To view these articles, visit https://doi.org/10.1111/apt.17570 and https://doi.org/10.1111/apt.17750
-
Letter: Tofacitinib, vedolizumab and ustekinumab in patients with ulcerative colitis—Authors' reply Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2023-11-20 Aakash Desai, Miguel Regueiro, Gursimran S. Kochhar
This article is linked to Kochhar et al papers. To view these articles, visit https://doi.org/10.1111/apt.17570 and https://doi.org/10.1111/apt.17697
-
Letter: The importance of histological assessment—a further stride in STRIDE Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2023-11-20 Vincenzo Villanacci, Mattia Bugatti, Stefania Zini, Rachele Del Sordo, Gabrio Bassotti
This article is linked to Dignass et al papers. To view these articles, visit https://doi.org/10.1111/apt.17622 and https://doi.org/10.1111/apt.17763
-
Letter: The importance of histological assessment—a further stride in STRIDE. Authors' reply Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2023-11-20 Axel Dignass, Stefan Rath, Thomas Kleindienst, Andreas Stallmach
This article is linked to Dignass et al papers. To view these articles, visit https://doi.org/10.1111/apt.17622 and https://doi.org/10.1111/apt.17717
-
Letter: Abdominal pain in inflammatory bowel disease patients in remission—A look beyond psychosocial factors Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2023-11-20 Gabrio Bassotti, Vincenzo Villanacci, Giovanni Maconi
This article is linked to Janssen et al papers. To view these articles, visit https://doi.org/10.1111/apt.17718 and https://doi.org/10.1111/apt.17775
-
Letter: Abdominal pain in patients with inflammatory bowel disease in remission - A look beyond psychosocial factors. Authors' reply Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2023-11-20 Ashkan Rezazadeh Ardabili, Laura Janssen, Zlatan Mujagic
This article is linked to Janssen et al papers. To view these articles, visit https://doi.org/10.1111/apt.17718 and https://doi.org/10.1111/apt.17745
-
Letter: Histological changes among asymptomatic chronic HBV carriers with normal alanine aminotransferase levels Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2023-11-20 Jannis Kountouras, Evangelos Kazakos, Anthia Gatopoulou, Stergios A. Polyzos, Maria Touloumtzi, Foteini Kyrailidi, Maria C. Mouratidou, Aggeliki Stogianni, Elisabeth Vardaka
This article is linked to Li et al papers. To view these articles, visit https://doi.org/10.1111/apt.17718 and https://doi.org/10.1111/apt.17784
-
Letter: Histological changes among asymptomatic chronic HBV carriers with normal alanine aminotransferase levels—Authors' reply Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2023-11-20 Shun Li, Lichen Shi, Jidong Jia, Yuanyuan Kong
This article is linked to Li et al papers. To view these articles, visit https://doi.org/10.1111/apt.17718 and https://doi.org/10.1111/apt.17760
-
Clinical trial: A Mediterranean diet is feasible and improves gastrointestinal and psychological symptoms in irritable bowel syndrome Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2023-11-15 Heidi M. Staudacher, Sophie Mahoney, Kim Canale, Rachelle S. Opie, Amy Loughman, Daniel So, Lauren Beswick, Chris Hair, Felice N. Jacka
-
Low liver fat in non-alcoholic steatohepatitis-related significant fibrosis and cirrhosis is associated with hepatocellular carcinoma, decompensation and mortality Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2023-11-15 Sung Won Lee, Daniel Q. Huang, Ricki Bettencourt, Veeral Ajmera, Monica Tincopa, Nabil Noureddin, Maral Amangurbanova, Harris Siddiqi, Egbert Madamba, Abdul M. Majzoub, Tarek Nayfeh, Nobuharu Tamaki, Namiki Izumi, Atsushi Nakajima, Masato Yoneda, Ramzan Idilman, Mesut Gumussoy, Digdem Kuru Oz, Ayse Erden, Rohit Loomba
-
Hepatocellular carcinoma risk decreases as time accrues following hepatitis C virus eradication Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2023-11-13 Philip Vutien, Nicole J. Kim, Andrew M. Moon, Kay M. Johnson, Kristin Berry, Pamela K. Green, George N. Ioannou
-
Trends in the prevalence rates and predictive factors of coeliac disease: A long-term nationwide follow-up study Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2023-11-09 Juha Taavela, Kalle Kurppa, Tuija Jääskeläinen, Niina E. Kaartinen, Harri Rissanen, Heini Huhtala, Markku Mäki, Katri Kaukinen
-
Treatment rates and factors associated with direct-acting antiviral therapy for insured patients with hepatitis C-related hepatocellular carcinoma – A real-world nationwide study Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2023-11-08 Leslie Y. Kam, Yee Hui Yeo, Fanpu Ji, Linda Henry, Ramsey Cheung, Mindie H. Nguyen
-
Letter: “No first among equals”—Authors' reply’ Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2023-11-06 Maia Kayal, Jean Frederic Colombel
We thank Dr. Arora et al for their letter1 in response to our systematic review on scores used to predict outcomes in acute severe ulcerative colitis (ASUC), and appreciate the additional information regarding their excellent work in developing and validating the AIIMS index.2-4 We agree the Lichtiger index is a valuable tool for the diagnosis of ASUC and assessment of steroid failure. However, since
-
Clinical trial: predictive factors for response to gut-directed hypnotherapy for refractory irritable bowel syndrome, a post hoc analysis Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2023-11-05 Jade Devenney, Syed S. Hasan, Julie Morris, Peter J. Whorwell, Dipesh H. Vasant
-
Letter: Comparing first-line infliximab and vedolizumab for ulcerative colitis—It depends on how you use the drug. Authors' reply Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2023-11-04 Bernd Bokemeyer, Sandra Plachta-Danielzik
Editors, We thank Dr. Con et al for their interest in our study and their insightful comments.1, 2 We would like to address their points and provide additional context to our findings. As a potential explanation for the inferior long-term effectiveness of infliximab in our study, Con et al propose an immunological secondary loss of efficacy due to antibody formation. We acknowledge this as an important
-
Letter: ‘No first among equals’ Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2023-11-03 Umang Arora, Saurabh Kedia, Simon Travis, Vineet Ahuja
Dr. Kayal and colleagues are to be congratulated on their efforts to summarise systematically the existing literature on prognostic scoring in acute severe ulcerative colitis (ASUC) while also addressing their inherent limitations.1 First, we would like to highlight a discrepancy in the bibliography namely our centre's publication introducing the AIIMS index for predicting steroid failure (Ref 20)
-
Systematic review and meta-analysis: Foods, drinks and diets and their effect on chronic constipation in adults Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2023-10-31 Alice Van Der Schoot, Zoi Katsirma, Kevin Whelan, Eirini Dimidi
-
Atherosclerotic cardiovascular disease risk profile of patients with chronic hepatitis B treated with tenofovir alafenamide or tenofovir disoproxil fumarate for 96 weeks Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2023-10-31 Scott K. Fung, Calvin Q. Pan, Grace Lai-Hung Wong, Wai-Kay Seto, Sang Hoon Ahn, Chi-Yi Chen, Hie-Won L. Hann, Maciej S. Jablkowski, Yoon Jun Kim, Cihan Yurdaydin, Cheng-Yuan Peng, Tuan Nguyen, Hiroshi Yatsuhashi, John F. Flaherty, Leland J. Yee, Frida Abramov, Hongyuan Wang, Dzhamal Abdurakhmanov, Young-Suk Lim, Maria Buti
-
Open-label, clinical trial extension: Two-year safety and efficacy results of seladelpar in patients with primary biliary cholangitis Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2023-10-30 Marlyn J. Mayo, John M. Vierling, Christopher L. Bowlus, Cynthia Levy, Gideon M. Hirschfield, Guy W. Neff, Michael R. Galambos, Stuart C. Gordon, Brian B. Borg, Stephen A. Harrison, Paul J. Thuluvath, Aparna Goel, Mitchell L. Shiffman, Mark G. Swain, David E. J. Jones, Palak Trivedi, Andreas E. Kremer, Richard J. Aspinall, David A. Sheridan, Yvonne Dörffel, Ke Yang, Yun-Jung Choi, Charles A. McWherter
-
Increased spine bone density in patients with chronic hepatitis B switched to tenofovir alafenamide: A prospective, multinational study Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2023-10-26 Eiichi Ogawa, Dae Won Jun, Hidenori Toyoda, Yao-Chun Hsu, Eileen L. Yoon, Sang Bong Ahn, Ming-Lun Yeh, Son Do, Huy N. Trinh, Hirokazu Takahashi, Masaru Enomoto, Norifumi Kawada, Satoshi Yasuda, Cheng-Hao Tseng, Keigo Kawashima, Han Ah Lee, Kaori Inoue, Hiroaki Haga, Ai-Thien Do, Mayumi Maeda, Joseph H. Hoang, Ramsey Cheung, Yoshiyuki Ueno, Yuichiro Eguchi, Norihiro Furusyo, Ming-Lung Yu, Yasuhito Tanaka
-
Editorial: PPIs and gastric cancer–Are we dealing with a carcinogen? Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2023-10-26 Peter Malfertheiner, Christian Schulz, Colin W. Howden
This article is linked to Gong et al papers. To view these articles, visit https://doi.org/10.1111/apt.17676 and https://doi.org/10.1111/apt.17741
-
Editorial: PPIs and gastric cancer – Are we dealing with a carcinogen? Authors' reply Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2023-10-26 Eun Jeong Gong, Hye-Kyung Jung
This article is linked to Gong et al papers. To view these articles, visit https://doi.org/10.1111/apt.17676 and https://doi.org/10.1111/apt.17691
-
Editorial: HBsAg seroclearance after pegylated interferon treatment—The beginning of the end Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2023-10-26 Lung-Yi Mak
This article is linked to Gao et al papers. To view these articles, visit https://doi.org/10.1111/apt.17670 and https://doi.org/10.1111/apt.17710
-
Editorial: HBsAg seroclearance after pegylated interferon treatment—The beginning of the end. Authors' reply Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2023-10-26 Na Gao, Guiwen Guan, Qiyi Zhao, Zhiliang Gao
This article is linked to Gao et al papers. To view these articles, visit https://doi.org/10.1111/apt.17670 and https://doi.org/10.1111/apt.17690
-
Editorial: Can liver fat quantification stratify cardiovascular risk in type 2 diabetes? Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2023-10-26 Sherlot Juan Song, Terry Cheuk-Fung Yip, Grace Lai-Hung Wong, Vincent Wai-Sun Wong, Ken Liu
This article is linked to Kuo et al papers. To view these articles, visit https://doi.org/10.1111/apt.17637 and https://doi.org/10.1111/apt.17742
-
Editorial: Can liver fat quantification stratify cardiovascular risk in type 2 diabetes? Authors' reply Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2023-10-26 Selena Z. Kuo, Rohit Loomba
This article is linked to Kuo et al papers. To view these articles, visit https://doi.org/10.1111/apt.17637 and https://doi.org/10.1111/apt.17677
-
Editorial: Noninvasive tests for metabolic dysfunction-associated steatotic liver disease: A refinement of the Nash-FibroTest for type 2 diabetes mellitus Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2023-10-26 Chen-Hua Liu
This article is linked to Poynard et al paper. To view this article, visit https://doi.org/10.1111/apt.17688
-
Editorial: The role of point-of-care echocardiography for assessing cirrhotic cardiomyopathy and predicting clinical outcomes in acute-on-chronic liver failure with severe sepsis Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2023-10-26 Markus Kimmann, Jonel Trebicka
This article is linked to Kajal et al paper. To view this article, visit https://doi.org/10.1111/apt.17695
-
Letter: A step forward towards a standard FMT protocol for IBS Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2023-10-26 Magdy El-Salhy, Odd Helge Gilja, Jan Gunnar Hatlebakk
This article is linked to Yau et al paper. To view this article, visit https://doi.org/10.1111/apt.17703
-
Liver biopsy for assessment of suspected drug-induced liver injury in metabolic dysfunction-associated steatohepatitis clinical trials: Expert consensus from the Liver Forum Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2023-10-25 Melissa Palmer, David E. Kleiner, Zachary Goodman, Elizabeth Brunt, Mark I. Avigan, Arie Regev, Paul H. Hayashi, James H. Lewis, Ruby Mehta, Stephen A. Harrison, Massimo Siciliano, Charles A. McWherter, Raj Vuppalanchi, Cynthia Behling, Veronica Miller, Naga Chalasani, Arun J. Sanyal
-
Retrospective cohort study: Effect of age as a barrier to diagnosis of eosinophilic oesophagitis Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2023-10-25 Akshatha Kiran, Evan S. Dellon, Craig C. Reed
-
Systematic review: Glycomics as diagnostic markers for hepatocellular carcinoma Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2023-10-25 Emma Butaye, Nicky Somers, Lorenz Grossar, Nele Pauwels, Sander Lefere, Lindsey Devisscher, Sarah Raevens, Anja Geerts, Leander Meuris, Nico Callewaert, Hans Van Vlierberghe, Xavier Verhelst
-
Recent trends and risk factors associated with Clostridioides difficile infections in hospitalized patients with inflammatory bowel disease Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2023-10-24 Ellen J. Spartz, Lauren C. DeDecker, Kush M. Fansiwala, Shaya Noorian, Andrew R. Roney, Shahrad Hakimian, Jenny S. Sauk, Po-Hung Chen, Berkeley N. Limketkai
-
Body weight increase and metabolic derangements after tenofovir disoproxil fumarate switch to tenofovir alafenamide in patients with chronic hepatitis B Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2023-10-16 Pin-Nan Cheng, I-Cher Feng, Jyh-Jou Chen, Hsing-Tao Kuo, Pei-Lun Lee, Ming-Lung Yu, Yen-Cheng Chiu, Hung-Chih Chiu, Shih-Chieh Chien, Pei-Jer Chen, Chun-Jen Liu
-
Superficial oesophageal mucosal innervation may contribute to severity of symptoms in oesophageal motility disorders Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2023-10-16 Akinari Sawada, Mengyu Zhang, Ahsen Ustaoglu, Kornilia Nikaki, Chung Lee, Philip Woodland, Etsuro Yazaki, Shingo Takashima, Masaki Ominami, Fumio Tanaka, Fabio Nachman, Andrés Ditaranto, Joaquín Agotegaray, Claudio Bilder, Edoardo Savarino, C. Prakash Gyawali, Roberto Penagini, Yasuhiro Fujiwara, Daniel Sifrim
-
Long-term follow-up of web-based and group-based behavioural intervention in NAFLD in a real world clinical setting Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2023-10-16 Maria Letizia Petroni, Santo Colosimo, Lucia Brodosi, Angelo Armandi, Flavio Bertini, Danilo Montesi, Elisabetta Bugianesi, Giulio Marchesini
-
The assessment of segmental healing by the Modified Mayo Endoscopic Score (MMES) complements the prediction of long-term clinical outcomes in patients with ulcerative colitis Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2023-10-16 Matthias Lenfant, Bram Verstockt, João Sabino, Séverine Vermeire, Marc Ferrante
-
Editorial: Unravelling the fibres—low dietary fibre may lower risk of developing IBD Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2023-10-13 Emily Walsh Lopes, Hamed Khalili
This article is linked to Deng et al papers. To view these articles, visit https://doi.org/10.1111/apt.17649 and https://doi.org/10.1111/apt.17730
-
Editorial: Unravelling the fibres—low dietary fibre may lower risk of developing IBD. Authors' reply Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2023-10-13 Lintao Dan, Xiaoyan Wang, Jie Chen
This article is linked to Deng et al papers. To view these articles, visit https://doi.org/10.1111/apt.17649 and https://doi.org/10.1111/apt.17663
-
Editorial: Time to consider early treatment for chronic hepatitis B in both children and adults Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2023-10-13 Won-Mook Choi, Young-Suk Lim
This article is linked to Wu et al papers. To view these articles, visit https://doi.org/10.1111/apt.17667 and https://doi.org/10.1111/apt.17685
-
Editorial: Time to consider early treatment for chronic hepatitis B in both children and adults—authors' reply Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2023-10-13 Xiaoli Wu, Songxu Peng
This article is linked to Wu et al papers. To view these articles, visit https://doi.org/10.1111/apt.17667 and https://doi.org/10.1111/apt.17679
-
Editorial: Continuous monitoring to improve outcome of treatment—the next step towards safe and effective faecal microbiota transplantation Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2023-10-13 Josbert J. Keller, Elisabeth M. Terveer
This article is linked to Baunwall et al papers. To view these articles, visit https://doi.org/10.1111/apt.17642 and https://doi.org/10.1111/apt.17721
-
Editorial: Continuous monitoring to improve outcome of treatment—the next step towards safe and effective faecal microbiota transplantation. Authors' reply Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2023-10-13 Simon Mark Dahl Baunwall, Mette Mejlby Hansen, Sara Ellegaard Andreasen, Marcel Kjærsgaard Eriksen, Nina Rågård, Jens Kelsen, Anne Karmisholt Grosen, Susan Mikkelsen, Christian Erikstrup, Jens Frederik Dahlerup, Christian Lodberg Hvas
This article is linked to Baunwall et al papers. To view these articles, visit https://doi.org/10.1111/apt.17642 and https://doi.org/10.1111/apt.17694
-
Editorial: Faecal microbiota transplantation in IBS—Moving closer or away from success? Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2023-10-13 Elvira Lesmana, Madhusudan Grover
This article is linked to Yau et al papers. To view these articles, visit https://doi.org/10.1111/apt.17703 and https://doi.org/10.1111/apt.17729
-
Editorial: Faecal microbiota transplantation in IBS—Moving closer or away from success? Authors' reply Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2023-10-13 Qi Su, Yuk K. Yau, Siew C. Ng
This article is linked to Yau et al papers. To view these articles, visit https://doi.org/10.1111/apt.17703 and https://doi.org/10.1111/apt.17724
-
Letter: Consensus in international guidelines when discontinuing nucleos(t)ide analogue therapy in patients with chronic hepatitis B Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2023-10-13 Steven Trinh, Bridgette Andrew, Stephen Bloom, Rohit Sawhney
This article is linked to Hsu et al paper. To view this article, visit https://doi.org/10.1111/apt.17614
-
Letter: Rethinking the lower incidence of HCC in HIV-infected patients— A closer look at confounding factors Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2023-10-13 Guang-Zhao Shao, Wei Zhang, Yi-Fan Wu, Zhong-Qi Fan, Tian Yang, Guo-Yue Lv
This article is linked to Lui et al papers. To view these articles, visit https://doi.org/10.1111/apt.17654 and https://doi.org/10.1111/apt.17713
-
Letter: Rethinking the lower incidence of HCC in HIV-infected patients—A closer look at confounding factors. Authors' reply Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2023-10-13 Grace Lai-Hung Wong, Vicki Wing-Ki Hui, Yee-Tak Hui, Grace Chung-Yan Lui
This article is linked to Lui et al papers. To view these articles, visit https://doi.org/10.1111/apt.17654 and https://doi.org/10.1111/apt.17689
-
Letter: Exploring the clinical utility of ammonia in critically ill patients with cirrhosis: More to do? Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2023-10-13 Jia-Jia Dong, Qiong-Ying Zhang, Yi-Jing Cai
This article is linked to Cardoso et al papers. To view these articles, visit https://doi.org/10.1111/apt.17650 and https://doi.org/10.1111/apt.17725